3
H index
0
i10 index
15
Citations
Maastricht University (13% share) | 3 H index 0 i10 index 15 Citations RESEARCH PRODUCTION: 4 Articles RESEARCH ACTIVITY:
MORE DETAILS IN: ABOUT THIS REPORT:
|
Works with: Authors registered in RePEc who have co-authored more than one work in the last five years with Eduardo Urias. | Is cited by: | Cites to: |
Year ![]() | Title ![]() | Type ![]() | Cited ![]() |
---|---|---|---|
2018 | When access to drugs meets catch-up: Insights from the use of CL threats to improve access to ARV drugs in Brazil In: Research Policy. [Full Text][Citation analysis] | article | 5 |
2015 | Access to critical medicines: When are compulsory licenses effective in price negotiations? In: Social Science & Medicine. [Full Text][Citation analysis] | article | 6 |
2020 | Access to medicines after TRIPS: Is compulsory licensing an effective mechanism to lower drug prices? A review of the existing evidence In: Journal of International Business Policy. [Full Text][Citation analysis] | article | 4 |
2019 | The potential synergies between industrial and health policies for access to medicines: insights from the Brazilian policy of universal access to HIV/AIDS treatment In: Innovation and Development. [Full Text][Citation analysis] | article | 0 |
CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated February, 4 2025. Contact: CitEc Team